Why Is TWIST BIOSCIENCE COR (TWST) Stock Moving Today?

TWST stock surged 15.65% to $115.01 on Tuesday, driven primarily by the company's announcement of an upsized $300 million public offering. The offering, priced at $96 per share for 3.125 million shares, is intended to fund R&D and manufacturing expansion. The move comes amid recent regulatory filings and renewed investor interest in the firm's growth strategy.

What Happened

Twist Bioscience filed an 8-K with the SEC on August 5, disclosing a material definitive agreement and additional financial details. The company also announced the pricing of its upsized public offering, with shares set to close on August 6. The offering was upsized from an initial $250 million proposal and includes an option for underwriters to purchase additional shares. This expansion of capital raises expectations for increased R&D and production capabilities. The offering price of $96 per share represents a significant discount to the stock's current price, contributing to investor optimism.

What The Data Shows

Over the past eight sessions, TWST has gained 32.9%, rising from $86.54 to $115.01. The stock has traded within a 52-week range of $23.30 to $106.58, suggesting this move extends beyond typical volatility. The company's fundamentals remain unprofitable, with a trailing twelve-month net margin of -31.7% and earnings per share of -2.23. Despite this, revenue is growing at 19.2% year-to-date. Recent insider transactions show three executives sold shares totaling $14.8 million in the last 90 days, with the most recent sales occurring on August 3.

What To Watch

The stock is expected to close the offering on August 6. Investors should monitor the company's upcoming earnings and how the new capital is deployed. The stock's performance in the coming weeks will likely reflect progress in R&D and manufacturing expansion.